IL166779A0 - Method for the preparation of a silicic acid comprising extrudate said extrudate its use and a pharmaceutical composition comprising the said extrudate - Google Patents
Method for the preparation of a silicic acid comprising extrudate said extrudate its use and a pharmaceutical composition comprising the said extrudateInfo
- Publication number
- IL166779A0 IL166779A0 IL16677903A IL16677903A IL166779A0 IL 166779 A0 IL166779 A0 IL 166779A0 IL 16677903 A IL16677903 A IL 16677903A IL 16677903 A IL16677903 A IL 16677903A IL 166779 A0 IL166779 A0 IL 166779A0
- Authority
- IL
- Israel
- Prior art keywords
- extrudate
- silicic acid
- acid
- preparation
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/28—Silicates, e.g. perlites, zeolites or bentonites
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/20—Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Animal Husbandry (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02078336A EP1391426A1 (en) | 2002-08-12 | 2002-08-12 | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL166779A0 true IL166779A0 (en) | 2006-01-15 |
Family
ID=30775855
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16677903A IL166779A0 (en) | 2002-08-12 | 2003-08-12 | Method for the preparation of a silicic acid comprising extrudate said extrudate its use and a pharmaceutical composition comprising the said extrudate |
| IL166779A IL166779A (en) | 2002-08-12 | 2005-02-09 | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL166779A IL166779A (en) | 2002-08-12 | 2005-02-09 | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8771757B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1391426A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP4727227B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN101829143A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE428404T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003266283B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2494165C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1109228T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60327231D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1551763T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2325254T3 (cg-RX-API-DMAC7.html) |
| IL (2) | IL166779A0 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1551763E (cg-RX-API-DMAC7.html) |
| SI (1) | SI1551763T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004016551A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1391426A1 (en) | 2002-08-12 | 2004-02-25 | Bio Minerals N.V. | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| ITMI20050093A1 (it) * | 2005-01-25 | 2006-07-26 | Unimer Spa | Procedimento industriale per ottenere la granulazione di fertilizzanti mangimi e altri prodotti a partire da un procedimento preliminare di pellettatura |
| US7700083B2 (en) * | 2005-10-24 | 2010-04-20 | Kevin Meehan | Skin care composition for accelerated production of collagen proteins and method of fabricating same |
| FR2909558B1 (fr) * | 2006-12-12 | 2009-04-17 | Ceva Sante Animale Sa | Procede de fabrication de premelanges medicamenteux |
| ES2652114T3 (es) * | 2007-10-15 | 2018-01-31 | 7 Oaks Pharmaceutical Corporation | Una disolución que contiene silicato para uso en el tratamiento de melanoma |
| GB0720423D0 (en) * | 2007-10-19 | 2007-11-28 | Univ Leuven Kath | Method for brewing beer |
| GB0805279D0 (en) | 2008-03-20 | 2008-04-30 | Univ Nottingham Trent | Food supplement |
| WO2009127256A1 (en) * | 2008-04-17 | 2009-10-22 | Jisbrey, S.A | Hydronium stabilized and dissoluble silicic acid nanoparticles: preparation, stabilization and use |
| CZ2008841A3 (cs) * | 2008-12-23 | 2010-07-28 | Agra Group, A.S. | Pivo a nápoje na bázi piva a zpusob úpravy obsahu polyfenolu a kremíku v nich |
| GB0913255D0 (en) | 2009-07-30 | 2009-09-02 | Sisaf Ltd | Topical composition |
| DE102010008981A1 (de) * | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie |
| DE102010008982A1 (de) | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie |
| WO2012032364A1 (en) | 2010-09-06 | 2012-03-15 | Creogen D.O.O. | Stabilized solution of ortho-silicic acid based on salicylic acid as effective inhibitor of its polymerization, its preparation and use |
| WO2012035364A1 (en) | 2010-09-15 | 2012-03-22 | Creogen D.O.O. | Stabilized solution of ortho-silicic acid, its preparation and use |
| US10986647B2 (en) | 2017-05-04 | 2021-04-20 | At&T Intellectual Property I, L.P. | Management of group common downlink control channels in a wireless communications system |
| CN107988292B (zh) * | 2018-01-18 | 2023-12-26 | 江苏江山聚源生物技术有限公司 | 提高重组人源胶原蛋白稳定性的发酵工艺 |
| EP3549578A1 (en) * | 2018-04-06 | 2019-10-09 | Bio Minerals N.V. | Silicic acid formulation and use thereof |
| EP3632449A1 (en) | 2018-10-05 | 2020-04-08 | Bio Minerals N.V. | Silicic acids for use in the treatment of periodontitis |
| EP3650011A1 (en) * | 2018-11-09 | 2020-05-13 | Bio Minerals NV | Water soluble silicon-containing granulate |
| PL3662761T3 (pl) * | 2018-12-04 | 2021-11-02 | Dsm Ip Assets B.V. | Stabilne podczas przechowywania adsorbaty związków nitrooksy |
| EP3714879A1 (en) | 2019-03-28 | 2020-09-30 | Sisaf Ltd | Structured encapsulated silicon-containing particles |
| GB201904337D0 (en) | 2019-03-28 | 2019-05-15 | Sisaf Ltd | A delivery system |
| GB201904334D0 (en) | 2019-03-28 | 2019-05-15 | Sisaf Ltd | Carrier system for preparing herbaceous extracts |
| GB201904336D0 (en) | 2019-03-28 | 2019-05-15 | Sisaf Ltd | A delivery system |
| WO2020260413A1 (fr) | 2019-06-28 | 2020-12-30 | Tilman Sa | Composition comprenant au moins un triterpène et/ou au moins un triterpénoïde et/ou au moins une de leurs formes glycosylées |
| GB202104173D0 (en) * | 2021-03-24 | 2021-05-05 | Ab Vista | Animal feed composition |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL9400189A (nl) | 1994-02-07 | 1995-09-01 | Bio Pharma Sciences Bv | Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat. |
| FR2799758B1 (fr) * | 1999-10-15 | 2002-05-17 | Exsymol Sa | Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation |
| EP1110909A1 (en) * | 1999-12-24 | 2001-06-27 | Bio Minerals N.V. | Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use |
| EP1391426A1 (en) | 2002-08-12 | 2004-02-25 | Bio Minerals N.V. | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
-
2002
- 2002-08-12 EP EP02078336A patent/EP1391426A1/en not_active Withdrawn
-
2003
- 2003-08-12 CN CN201010144554A patent/CN101829143A/zh active Pending
- 2003-08-12 EP EP03787792A patent/EP1551763B1/en not_active Expired - Lifetime
- 2003-08-12 AU AU2003266283A patent/AU2003266283B2/en not_active Expired
- 2003-08-12 PT PT03787792T patent/PT1551763E/pt unknown
- 2003-08-12 JP JP2004528493A patent/JP4727227B2/ja not_active Expired - Lifetime
- 2003-08-12 AT AT03787792T patent/ATE428404T1/de active
- 2003-08-12 ES ES03787792T patent/ES2325254T3/es not_active Expired - Lifetime
- 2003-08-12 US US10/524,189 patent/US8771757B2/en active Active
- 2003-08-12 WO PCT/EP2003/009009 patent/WO2004016551A1/en not_active Ceased
- 2003-08-12 DE DE60327231T patent/DE60327231D1/de not_active Expired - Lifetime
- 2003-08-12 DK DK03787792T patent/DK1551763T3/da active
- 2003-08-12 IL IL16677903A patent/IL166779A0/xx unknown
- 2003-08-12 SI SI200331616T patent/SI1551763T1/sl unknown
- 2003-08-12 CN CNA03820875XA patent/CN1678524A/zh active Pending
- 2003-08-12 CA CA002494165A patent/CA2494165C/en not_active Expired - Lifetime
-
2005
- 2005-02-09 IL IL166779A patent/IL166779A/en active IP Right Grant
-
2009
- 2009-07-14 CY CY20091100732T patent/CY1109228T1/el unknown
-
2010
- 2010-08-06 JP JP2010178022A patent/JP2010265309A/ja active Pending
-
2014
- 2014-05-19 US US14/281,258 patent/US8945617B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20060099276A1 (en) | 2006-05-11 |
| AU2003266283A1 (en) | 2004-03-03 |
| CA2494165A1 (en) | 2004-02-26 |
| CN101829143A (zh) | 2010-09-15 |
| US20140255493A1 (en) | 2014-09-11 |
| US8945617B2 (en) | 2015-02-03 |
| EP1391426A1 (en) | 2004-02-25 |
| JP4727227B2 (ja) | 2011-07-20 |
| CN1678524A (zh) | 2005-10-05 |
| DE60327231D1 (de) | 2009-05-28 |
| SI1551763T1 (sl) | 2009-10-31 |
| WO2004016551A1 (en) | 2004-02-26 |
| CY1109228T1 (el) | 2014-07-02 |
| EP1551763B1 (en) | 2009-04-15 |
| JP2010265309A (ja) | 2010-11-25 |
| US8771757B2 (en) | 2014-07-08 |
| PT1551763E (pt) | 2009-07-07 |
| AU2003266283B2 (en) | 2008-04-10 |
| EP1551763A1 (en) | 2005-07-13 |
| ES2325254T3 (es) | 2009-08-31 |
| DK1551763T3 (da) | 2009-07-20 |
| JP2005535549A (ja) | 2005-11-24 |
| CA2494165C (en) | 2009-05-26 |
| IL166779A (en) | 2010-05-17 |
| ATE428404T1 (de) | 2009-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1551763T1 (sl) | Postopek za pripravo ekstrudata, ki vsebuje silicijevo kislino, njegova uporaba in farmacevtski sestavek, ki vsebuje navedeni ekstrudat | |
| US10456366B2 (en) | Composition and methods for tissue regeneration | |
| JP2006117700A5 (cg-RX-API-DMAC7.html) | ||
| CA2027483A1 (fr) | Procede de preparation d'une solution aqueuse effervescente ayant une action emolliente sur la cuticule des ongles, composition pour la mise en oeuvre dudit procede et traitement cosmetique correspondant | |
| JP2005535549A5 (cg-RX-API-DMAC7.html) | ||
| RU2004127960A (ru) | Применение композиций витамина d | |
| TW201424596A (zh) | 用於改善犬隻健康之方法 | |
| EA200501069A1 (ru) | Состав для местного применения и способы обработки старческой или повреждённой воздействием окружающей среды кожи | |
| WO2002064104A1 (en) | Methods for treating fingernails and toenails | |
| JP2002363035A (ja) | 育毛剤 | |
| WO2004046096A3 (en) | Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics | |
| EA200200718A1 (ru) | Физиологически активные средства на основе вицинальных дитиогликолей и их применение | |
| KR102214403B1 (ko) | 펩타이드 복합 마이크로니들 및 이를 포함하는 화장품 조성물 | |
| CN108456248A (zh) | 水解水母i型、ii型和v型胶原蛋白及其用途 | |
| EP1908455A1 (en) | Hair care preparation | |
| RU2015153242A (ru) | Действующее вещество для лечения саркопении | |
| MXPA03011622A (es) | Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas. | |
| KR101400971B1 (ko) | 실크 단백질의 가수 분해물을 함유하는 모발 성장 촉진용 화장료 조성물 | |
| CN1109677A (zh) | 减少脱发和/或促进头发再生的组合物 | |
| PE20050285A1 (es) | Composicion farmaceutica que comprende analogos ciclicos de somatostatina | |
| CN105274554A (zh) | 一种l-半胱氨酸的生产方法 | |
| CN117297107A (zh) | 一种促进细胞生长及抗衰老的胶原蛋白肽 | |
| KR101236526B1 (ko) | 실크단백질 가수분해물을 포함하는 모발성장 촉진용 조성물 | |
| CA2544277A1 (en) | Keratin gel and the types 2, 4 and 6 of collagens of frog protein for topical use or for lamina preparation use, such as dressing or powdering in food and complements use and in cosmetic mask manufacturing or in solutions used in cosmetic formulation and medical/pharmaceutical | |
| ATE403725T1 (de) | Cap-bindungsprotein |